A women's medical group is fighting cervical cancer by issuing guidelines that call for inoculating all girls ages 11 and 12. More than 10,000 new cases of cervical cancer will be diagnosed in the United States this year. At least 3,500 women will die.
However, a controversy has started a year, or more, before the vaccine will be ready for the public. In the hopes of heading off a confrontation, officials from the developing companies -- Merck & Co. and GlaxoSmithKline -- are meeting with advocacy groups to try to relieve their concerns. Merck is creating the drug to be used on 11 – 26 year old women.
"The guidelines state that routine vaccination with Gardasil is recommended for 11- and 12-year-old females and for females ages 13 to 26 who have not previously been vaccinated or who have not completed the full series, and that vaccination with Gardasil can be started at nine years of age," Merck said in a news release.
The American Medical Women's Association recommends that doctors check all women 30 years and older for the human papillomavirus, or HPV, that may cause the cancer. The 14,000-member group is also lobbying insurance companies to pay for the vaccine.
The group is planning on re-directing attention to the benefits of new tools to fight cervical cancer, which has a kill rate of 230,000 women annually. The association is taking a stand in favor of the vaccine. A politically volatile topic -- HPV can be transmitted through sexual contact.
"We wanted to reaffirm that girls really do need access to this vaccine," said Dr. Susan Ivey,the association's president and an adjunct associate professor at UC Berkeley's School of Public Health. "We wanted to frame the discussion in a public-health context, where what you really want is to make your population resistant to diseases and one way to do that is through vaccination."
The American Medical Women's Association is the first non-government body to recommend routine vaccination for young girls. Doctors say the vaccine is most effective when given before sexual activity starts.
The vaccine targets four strains of human papillomavirus. Many women carry HPV through their entire lifetimes, but most women are able to fight off an infections before they ever realize they have the virus.
Beyond the vaccine, the American Women's Medical Association is advocating wider use of a relatively new test that goes beyond the standard Pap smear that typically is used to check women for cervical cancer.
Christine Baze 38, underwent surgery and radiation and chemotherapy to treat an advanced case of cervical cancer. She hope the vaccine and HPV test will help a hundreds of women avoid her suffering.
"It's incredible the tools that are available to prevent cancer now," she said. "I just don't want anybody to have to go through what I went through ... and the good news is, they don't have to. We have an amazing opportunity to eliminate this cancer."
While the idea of a mandatory vaccine for a sexually transmitted disease has ignited a worldwide moral debate, the release of the drug was approved in the USA in June 2006.
At the moment, Canada is the only country actively proposing the vaccine for both boys and girls as it causes a cosmetic blemish when given to boys.
By: → Ethan Miller
However, a controversy has started a year, or more, before the vaccine will be ready for the public. In the hopes of heading off a confrontation, officials from the developing companies -- Merck & Co. and GlaxoSmithKline -- are meeting with advocacy groups to try to relieve their concerns. Merck is creating the drug to be used on 11 – 26 year old women.
"The guidelines state that routine vaccination with Gardasil is recommended for 11- and 12-year-old females and for females ages 13 to 26 who have not previously been vaccinated or who have not completed the full series, and that vaccination with Gardasil can be started at nine years of age," Merck said in a news release.
The American Medical Women's Association recommends that doctors check all women 30 years and older for the human papillomavirus, or HPV, that may cause the cancer. The 14,000-member group is also lobbying insurance companies to pay for the vaccine.
The group is planning on re-directing attention to the benefits of new tools to fight cervical cancer, which has a kill rate of 230,000 women annually. The association is taking a stand in favor of the vaccine. A politically volatile topic -- HPV can be transmitted through sexual contact.
"We wanted to reaffirm that girls really do need access to this vaccine," said Dr. Susan Ivey,the association's president and an adjunct associate professor at UC Berkeley's School of Public Health. "We wanted to frame the discussion in a public-health context, where what you really want is to make your population resistant to diseases and one way to do that is through vaccination."
The American Medical Women's Association is the first non-government body to recommend routine vaccination for young girls. Doctors say the vaccine is most effective when given before sexual activity starts.
The vaccine targets four strains of human papillomavirus. Many women carry HPV through their entire lifetimes, but most women are able to fight off an infections before they ever realize they have the virus.
Beyond the vaccine, the American Women's Medical Association is advocating wider use of a relatively new test that goes beyond the standard Pap smear that typically is used to check women for cervical cancer.
Christine Baze 38, underwent surgery and radiation and chemotherapy to treat an advanced case of cervical cancer. She hope the vaccine and HPV test will help a hundreds of women avoid her suffering.
"It's incredible the tools that are available to prevent cancer now," she said. "I just don't want anybody to have to go through what I went through ... and the good news is, they don't have to. We have an amazing opportunity to eliminate this cancer."
While the idea of a mandatory vaccine for a sexually transmitted disease has ignited a worldwide moral debate, the release of the drug was approved in the USA in June 2006.
At the moment, Canada is the only country actively proposing the vaccine for both boys and girls as it causes a cosmetic blemish when given to boys.
By: → Ethan Miller
